Search results for "HOMA"

showing 10 items of 956 documents

Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors

2011

Gene DosageReceptor Protein-Tyrosine KinasesProtein-Tyrosine KinasesBiologyPrognosisPathology and Forensic MedicineCohort StudiesSurvival RateNeuroblastomaExpression (architecture)Cancer researchHumansAnaplastic lymphoma kinaseAnaplastic Lymphoma KinaseChromosome DeletionIn Situ Hybridization FluorescenceNeoplasm StagingHuman Pathology
researchProduct

Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes.

2011

Abstract Abstract 2494 Background. Burkitt lymphoma (BL) is currently listed in the WHO classification of lymphoid tumors as a single genetic and morphological entity with variation in clinical presentation. In particular, three clinical subsets of BL are recognized: endemic (eBL), sporadic (sBL) and immunodeficiency associated (ID-BL). Each affects different populations and can present with different features. So far, possible differences in their gene expression profiles (GEP) have not been investigated. In this study we aimed to 1) assess whether BL subtypes present with differences in their GEP; 2) investigate the relationship of the different BL subtypes with the non-neoplastic cellula…

Gene Expression Profiles; burkitt lymphomaGene expression analysieducationTransplantation HeterologousImmunologyMice NudeBiologyburkitt lymphomaBiochemistryBurkitt lymphoma.Micehemic and lymphatic diseasesCell Line TumormedicineAnimalsCluster AnalysisHumansRegulation of gene expressionGeneticsGene Expression ProfilesGENE EXPRESSION PROFILEMicroarray analysis techniquesGene Expression ProfilingGerminal centerCell BiologyHematologymedicine.diseaseMicroarray AnalysisPhenotypeLymphomaGene expression profilingTransplantationGene Expression Regulation NeoplasticPhenotypeBurkitt's lymphomaNeoplasm TransplantationGene expression analysis;Burkitt lymphoma.
researchProduct

Hemocyanin subunit organization of the gastropod Rapana thomasiana

1999

Abstract RtH1 and RtH2, the two hemocyanin isoforms of the prosobranch gastropod Rapana thomasiana, have been purified by anion-exchange chromatography and studied by SDS–PAGE and immunoelectrophoresis. Both subunit types are built up of eight functional units (FUs). Under reducing conditions subunit RtH2 splits into two fragments, RtH2- a – f and RtH2- gh, suggesting the presence of a disulfide bridge between FU2- f and FU2- g. By proteolytic cleavage of the subunits into three-, two-, and single-FU fragments, purification of fragments by HPLC, N-terminal sequencing of the peptides, and crossed-line immunoelectrophoresis, FUs- a – h of RtH2 and FU- a, FU- d, FU- e, and FU- f of RtH1 were i…

Gene isoformSubunitProtein subunitmedicine.medical_treatmentMolecular Sequence DataBiophysicsImmunoelectrophoresisBiologyMegathura crenulataCleavage (embryo)BiochemistryHigh-performance liquid chromatographyHemocyaninRapana thomasianamedicineAnimalsProtein IsoformsAmino Acid SequenceProtein Structure QuaternaryMolecular BiologyGasteropodsmedicine.diagnostic_testPancreatic ElastaseImmunochemistryStructureHemocyaninbiology.organism_classificationMolecular biologyPeptide FragmentsMolluscaHemocyanin; Gasteropods; Structure; SubunitHemocyaninsImmunoelectrophoresis Two-Dimensional
researchProduct

Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients

2001

Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients

Genetic MarkersTelomeraseDiseaseBiologyPathology and Forensic MedicineNeoplasmsBiomarkers TumormedicineHumansBlood testTelomerase reverse transcriptaseRNA MessengerLymphoma FollicularTelomeraseMolecular BiologyMessenger RNAmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionCancerCell BiologyPrognosismedicine.diseaseNucleotidyltransferaseMolecular biologyDNA-Binding ProteinsReverse transcription polymerase chain reactionRNAColorectal NeoplasmsLaboratory Investigation
researchProduct

Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: A rare case report and review of the literature

2017

Abstract Background Oral verruciform xanthoma is an uncommon benign lesion. Although oral verruciform xanthoma occurs in healthy individuals, it has been also reported in association with some inflammatory conditions. The aim of this study is to report a case of oral verruciform xanthoma associated with chronic graft-versus-host disease and to review the literature on this topic. Case presentation A 47-year-old Caucasian male presented to the Sector of Oral Medicine “V. Margiotta”, University Policlinic “P. Giaccone” of Palermo complaining of a mass on the gingiva. He first noticed the painless mass 1 year ago. He reported to have undergone allogenic hematopoietic stem cell transplantation …

Genetics and Molecular Biology (all)MaleVerruciform xanthomaBiopsylcsh:MedicineGraft vs Host DiseaseCase ReportBiochemistryChronic graft versus-host-disease; Erythroplakia; Oral potential malignant disorder; Verruciform xanthoma; Biochemistry Genetics and Molecular Biology (all)030207 dermatology & venereal diseases0302 clinical medicinelcsh:QH301-705.5Verruciform xanthomaErythroplakiamedicine.diagnostic_testChronic graft versus-host-diseaseHematopoietic Stem Cell TransplantationMED/28 - MALATTIE ODONTOSTOMATOLOGICHEGeneral MedicineMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.anatomical_structure030220 oncology & carcinogenesisOral erythroplakiamedicine.symptommedicine.medical_specialtyGeneral Biochemistry Genetics and Molecular BiologyOral potential malignant disorder03 medical and health sciencesTongueBiopsymedicineXanthomatosisLS7_3Humanslcsh:Science (General)Biochemistry Genetics and Molecular Biology (all)business.industrylcsh:RAmbientaleNodule (medicine)medicine.diseaseDermatologystomatognathic diseaseslcsh:Biology (General)ErythroplasiaChronic DiseaseHard palatebusinessMouth DiseasesOral medicineErythroplakialcsh:Q1-390
researchProduct

Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph)

2011

Previous studies have suggested an important role for the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signalling pathway in tumour development. Therefore, we explored genetic variants in JAK-STAT pathway associated genes with lymphoma risk. In samples of the EpiLymph case-control study we genotyped 1536 single nucleotide polymorphisms (SNPs) using GoldenGate BeadArray™ Technology (Illumina, San Diego, CA, USA). Here, we report the associations between selected SNPs and haplotypes of the JAK-STAT pathway and risk of Hodgkin lymphoma (HL), B-cell non-Hodgkin lymphoma (B-NHL) and most frequent B-NHL subtypes. Among 210 relevant JAK-STAT pathway-related SNPs, polymo…

Genetics0303 health sciencesmedicine.medical_specialtyHematologyHaplotypeJAK-STAT signaling pathwaySingle-nucleotide polymorphismHematologyBiologymedicine.diseaseLymphomaSTAT5A03 medical and health sciences0302 clinical medicineimmune system diseaseshemic and lymphatic diseases030220 oncology & carcinogenesisInternal medicineIL12ACancer researchmedicineSNP030304 developmental biologyBritish Journal of Haematology
researchProduct

Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism ofALKactivation in neuroblastoma tumors

2014

Anaplastic lymphoma kinase (ALK) has been demonstrated to be deregulated in sporadic as well as in familiar cases of neuroblastoma (NB). Whereas ALK-fusion proteins are common in lymphoma and lung cancer, there are few reports of ALK rearrangements in NB indicating that ALK mainly exerts its oncogenic capacity via activating mutations and/or overexpression in this tumor type. In this study, 332 NB tumors and 13 cell lines were screened by high resolution single nucleotide polymorphism microarray. Gain of 2p was detected in 23% (60/332) of primary tumors and 46% (6/13) of cell lines, while breakpoints at the ALK locus were detected in four primary tumors and two cell lines. These were furthe…

GeneticsCancer ResearchKinaseGene rearrangementAmpliconBiologymedicine.diseasemedicine.disease_causeLymphomaExonhemic and lymphatic diseasesNeuroblastomaGeneticsmedicineCancer researchAnaplastic lymphoma kinaseCarcinogenesisGenes, Chromosomes and Cancer
researchProduct

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

2021

Aim: Recessive genetic variation is thought to play a role in non-Hodgkin lymphoma (NHL) etiology. Runs of homozygosity (ROH), defined based on long, continuous segments of homozygous SNPs, can be used to estimate both measured and unmeasured recessive genetic variation. We sought to examine genome-wide homozygosity and NHL risk.Methods: We used data from eight genome-wide association studies of four common NHL subtypes: 3061 chronic lymphocytic leukemia (CLL), 3814 diffuse large B-cell lymphoma (DLBCL), 2784 follicular lymphoma (FL), and 808 marginal zone lymphoma (MZL) cases, as well as 9374 controls. We examined the effect of homozygous variation on risk by: (1) estimating the fraction o…

GeneticsChronic lymphocytic leukemiadiffuse large B-cell lymphomaFollicular lymphomaSingle-nucleotide polymorphismRuns of HomozygosityBiologymedicine.diseasemarginal zone lymphomaArticlefollicular lymphomaimmune system diseaseshemic and lymphatic diseasesGenetic variationmedicinechronic lymphocytic leukemiahomozygosityDiffuse large B-cell lymphomaInbreedingNon-Hodgkin lymphomaGenetic associationJournal of Translational Genetics and Genomics
researchProduct

Over 30% of Patients with Splenic Marginal Zone Lymphoma Express Distinctive Antigen Receptors Utilizing a Single Immunoglogulin Variable Gene: Impli…

2010

Abstract Abstract 634 We systematically explored the immunoglobulin (IG) gene repertoire in 337 cases with splenic marginal-zone lymphoma (SMZL), by far the largest series yet. To resolve classification uncertainties, we included in the analysis only cases with a diagnosis of SMZL based on spleen histopathological findings or cases fulfilling the 2008 SBLG criteria (Matutes et al. Leukemia 2008). We here report that the IG heavy variable (IGHV) gene repertoire in SMZL is remarkably biased, with only three genes accounting for 45.8% of cases (IGHV1-2, 24.9%; IGHV4-34, 12.8%; IGHV3-23: 8.1%, respectively), significantly extending previous similar observations. Particularly for the IGHV1-2 gen…

GeneticsImmunologyCell BiologyHematologyBiologymedicine.diseaseBiochemistryLymphomamedicine.anatomical_structureImmunologymedicineRed pulpSplenic marginal zone lymphomaAlleleFramework regionIGHV@GeneDominance (genetics)
researchProduct

Distinctive Patterns of Intraclonal Diversification In IGHV1-2*04 Immunoglobulin Receptors of Patients with Splenic Marginal Zone Lymphoma: A of Ongo…

2011

Abstract Abstract 2638 We recently demonstrated that over 30% of cases with splenic marginal-zone lymphoma (SMZL) express distinctive immunoglobulin (IG) receptors that utilize a single polymorphic variant of the IGHV1-2 gene (IGHV1-2*04) and also exhibit restricted antigen-binding site motifs and precise targeting of somatic hypermutation (SHM). On these grounds, we proposed the existence of molecular subtypes of SMZL defined by immunogenetic analysis of the IG receptors with implications for selection by specific (super) antigenic element(s) in the development of at least a major subset of SMZL. In order to gain insight as to whether antigen involvement is relevant only prior to the malig…

GeneticsImmunologySomatic hypermutationCell BiologyHematologyComplementarity determining regionBiologymedicine.diseaseBiochemistryGermlineSubcloningmedicinebiology.proteinSplenic marginal zone lymphomaAntibodyIGHV@GeneBlood
researchProduct